One year anniversary for UCLH healthy volunteer registry for research 5 February 2026 239 people have so far joined the registry of healthy volunteers willing to be contacted about taking part in health research.
New combination therapy trial for lung cancer open to recruitment 20 January 2026 The global study involves patients with advanced lung cancer.
CRF end of year newsletter published 22 December 2025 An end of year newsletter from the NIHR UCLH Clinical Research Facility is out now.
First participant dosed in clinical trial of new rectal cancer investigational drug at UCLH 16 December 2025 The FORTRESS study is looking at a novel treatment for locally advanced rectal cancer.
First participant in the UK recruited for new trial of advanced solid tumours 30 October 2025 The global study is taking place in 18 countries.
First UK patient uses thought to control computer hours after Neuralink implant 28 October 2025 A patient with motor neurone disease was able to control a computer just by using his thoughts following the surgery at UCLH.
Largest-ever Parkinson’s disease trial opens across UK 16 October 2025 The £26 million project is accelerating the search for effective treatments.
Huntington’s Disease gene therapy shows 75 per cent slowing of disease progression 24 September 2025 The study is BRC supported and took place at the NIHR UCLH Clinical Research Facility.
New brain haemorrhage drug trial recruits first UK participant 30 July 2025 UCLH has recruited the first UK participant to a study in a condition affecting the blood vessels in the brain.
Two poster awards for our staff at NIHR CRF and BRC Conference 22 July 2025 Staff from our CRF and BRC won two of the five poster awards on offer at a national CRF and BRC conference. Read more
Next-generation treatment for multiple myeloma shows early promise 11 July 2025 Initial results from an early phase study demonstrate that patients whose disease has come back showed a 100% overall response rate at the clinically recommended dose in patients who had received previous standard therapies.
New AI tool developed to enhance support offered by Joint Research Office 8 July 2025 The tool makes it easier for visitors to the site to find the information they need. Read more
UCLH supports national campaign calling for more research participation 27 June 2025 UCLH is supporting a new UK-wide health and care research registry, as part of the nation’s biggest-ever recruitment drive to clinical trials.
First treatment for rare disease approved by UK medicines regulator 22 May 2025 UCL and UCLH led the UK trial in the rare neurodegenerative disease Friedreich’s ataxia.
UCLH recruits first participant in Europe for a new trial in muscular dystrophy 25 April 2025 Myotonic Dystrophy Type 1 (DM1) is a genetic condition and type of muscular dystrophy that causes progressive muscle weakness and wasting.
